Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors
Roman V. Uzhachenko(State Research Center of Virology and Biotechnology VECTOR), Anna E. Vilgelm(The Ohio State University), Hunter Lawrence(Vanderbilt University), Ann Richmond, Stacey Mont(Vanderbilt University), Gregory D. Ayers(Vanderbilt University Medical Center), Carlos L. Arteaga(The University of Texas Southwestern Medical Center), Sheau‐Chiann Chen(Vanderbilt University Medical Center), David G. DeNardo(Washington University in St. Louis), Zhufeng Ouyang(The Ohio State University Wexner Medical Center), Nabil Saleh(Ain Shams University), Ashlyn Blevins(Vanderbilt University), Chengli Shen(The Ohio State University Wexner Medical Center), Vijaya Bharti(Vanderbilt University)
Cited by 18
Related Papers
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
|Cancer Research|2012|941
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
|Breast Cancer Research|2007|679
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|580
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
|Breast Cancer Research|2011|463